The 2024 Access to Medicine Index, published by the Access to Medicine Foundation (ATMF), paints a stark picture of the ...

Pfizer will work with Ampersand Biomedicines and Montai Therapeutics to find drugs for obesity and lung cancer, respectively, ...

Michael Saylor set to make a brief, three-minute case for Bitcoin investment to Microsoft’s directors. Microsoft will have a ...

Innoviva ( (INVA) ) has released its Q3 earnings. Here is a breakdown of the information Innoviva presented to its investors.Don't Miss out on ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, ...

The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R ...

Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the use of GLP-1 receptor agonists, ...

We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are going to take a look at where ...

A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange ...

GSK’s linerixibat helped reduce itch in patients with a rare bile duct disease, meeting its primary endpoint in a late-stage ...

Panelists in this recent #TrendTalks discussion, “Activating Omnichannel Without Omniburden, sponsored by Relevate Health,” ...

GSK's phase 3 GLISTEN trial demonstrated linerixibat's potential to treat relentless itch in PBC patients, meeting its ...